Business Context and Reporting Period
Company: Oramed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 18, 2011
Event: Regulation FD Disclosure regarding a scheduled presentation at a medical conference.
Key Financial Metrics
This filing is a current report regarding a corporate event and does not contain financial statements. The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes or operational updates were reported in this filing. The document solely announces a future presentation by company management.
Guidance, Outlook, and Management Commentary
- Conference Presentation: Oramed Pharmaceuticals Inc. was selected to present at The 1st Asia Pacific Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension in Shanghai, China.
- Presenter: Roy Eldor, M.D., Director of Medical Affairs.
- Timing: Friday, June 3, 2011, from 10:30 AM to 12:00 PM in Hall A at the exhibition center.
- Exhibits: A press release dated May 18, 2011, is attached as Exhibit 99.1.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for specific details on the presentation topic.
- Confirm the company's attendance and presentation status at the June 3, 2011, conference in Shanghai.
- Review subsequent filings for any financial updates or clinical data resulting from this presentation.